Bad Oeynhausen, Germany

Margret Oethinger

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Margret Oethinger: Innovator in Microbial Resistance Research

Introduction

Margret Oethinger is a prominent inventor based in Bad Oeynhausen, Germany. She has made significant contributions to the field of microbiology, particularly in understanding and combating drug resistance in microbes. Her innovative work has implications for the treatment of infections and the development of new antimicrobial strategies.

Latest Patents

Margret Oethinger holds a patent titled "Methods of screening for compounds that reduce microbial resistance to fluoroquinolones." This patent represents an advancement in controlling drug resistance in microbes. The methods and compositions outlined in her patent focus on the role of AcrAB-like efflux pumps in controlling resistance to drugs, even in highly resistant microbes. The patent provides methods for treating infections, screening for inhibitors of AcrAB-like efflux pumps, and enhancing the antimicrobial activity of drugs. Additionally, it includes pharmaceutical compositions comprising an inhibitor of an AcrAB-like efflux pump and an antimicrobial agent.

Career Highlights

Oethinger has had a distinguished career, contributing to the scientific community through her research and innovations. Her work has been instrumental in advancing our understanding of microbial resistance and developing effective treatment strategies.

Collaborations

Margret Oethinger has collaborated with notable professionals in her field, including Stuart B. Levy. These collaborations have further enriched her research and expanded the impact of her work.

Conclusion

Margret Oethinger's contributions to the field of microbiology and her innovative approaches to combating drug resistance highlight her importance as an inventor. Her work continues to influence the development of new antimicrobial therapies and strategies for managing infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…